Out-Licensed Projects

Sprint Bioscience runs innovative projects from the discovery phase to clinical trials. Then we out-license projects to pharmaceutical companies who drive them through clinic and to the market. The aim is to conclude a major license agreement per year.

Our out-licensed projects are presented here.